Literature DB >> 2945933

The inability of adrenal androgens to stimulate the adult human prostate: an autopsy evaluation of men with hypogonadotropic hypogonadism and panhypopituitarism.

J E Oesterling, J I Epstein, P C Walsh.   

Abstract

Although it is well recognized that testicular androgens provide the major hormonal stimulus to the prostate the role of adrenal androgens is less certain. Recently, it has been suggested that total androgen ablation (adrenal and testicular) is necessary to achieve a complete response to hormonal therapy in men with carcinoma of the prostate. In an effort to elucidate the influence of adrenal androgens on prostatic growth, we reviewed autopsy findings in patients (mean age 65 years, with a range of 57 to 80 years) from 3 distinct groups: group 1 consisted of 4 men with neither adrenal nor testicular function since before puberty (panhypopituitarism), group 2 included 4 men with normal adrenal glands but no testicular function throughout life (hypogonadotropic hypogonadism or prepubertal castration) and group 3 consisted of 8 age-matched controls with normal adrenal glands and normal testes. To assess the degree of androgenic stimulation each prostate was examined by a genitourinary pathologist and was analyzed morphometrically with respect to epithelial cell height, epithelial cell height: nuclear height ratio, acinar area and short axis diameter of randomly selected acini. All prostates in groups 1 and 2 were atrophic histologically, while all prostates in group 3 were enlarged and demonstrated varying degrees of benign prostatic hyperplasia. Morphometric analysis of the 3 groups revealed the same results. For all 4 parameters studied morphometrically there was no statistical difference between groups 1 and 2. However, a statistical difference did exist for these criteria when either group 1 (p less than 0.0001) or group 2 (p less than 0.0001) was compared to group 3.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2945933     DOI: 10.1016/s0022-5347(17)45198-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Vaginal erogeneity, "female ejaculation," and the "Grafenberg spot".

Authors:  H Alzate
Journal:  Arch Sex Behav       Date:  1990-12

2.  Hormonal manipulation of prostatic cancer.

Authors:  F H Schröder
Journal:  BMJ       Date:  1991-12-14

3.  Characterization of Prostate Cancer in a Functional Eunuch.

Authors:  John J Stocking; Michael V Fiandalo; Elena A Pop; John H Wilton; Gissou Azabdaftari; James L Mohler
Journal:  J Natl Compr Canc Netw       Date:  2016-09       Impact factor: 11.908

4.  5alpha-reductase: history and clinical importance.

Authors:  Leonard S Marks
Journal:  Rev Urol       Date:  2004

Review 5.  Development of androgen-independent tumor cells and their implication for the treatment of prostatic cancer.

Authors:  J T Isaacs; N Kyprianou
Journal:  Urol Res       Date:  1987

6.  Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.

Authors:  Keisuke Okada; Hideaki Miyake; Takaki Ishida; Kenta Sumii; Noritoshi Enatsu; Koji Chiba; Kei Matsushita; Masato Fujisawa
Journal:  Am J Mens Health       Date:  2016-06-02

7.  Pharmacia Award 1990. The biological significance of low testosterone levels and of adrenal androgens in transplantable prostate cancer lines.

Authors:  W M van Weerden; A van Kreuningen; E P Moerings; F H de Jong; G J van Steenbrugge; F H Schröder
Journal:  Urol Res       Date:  1991
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.